Caricamento...
Monoclonal antibodies as anti-infective products: a promising future?
BACKGROUND: The paucity of licensed monoclonal antibodies (mAbs) in the infectious diseases arena strongly contrasts with the ready availability of these therapeutics for use in other conditions. AIMS: This narrative review aims to assess the potential of monoclonal antibody-based interventions for...
Salvato in:
| Pubblicato in: | Clin Microbiol Infect |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7128139/ https://ncbi.nlm.nih.gov/pubmed/29715552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2018.04.024 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|